![\"\"](\"http:\/\/stateofthenation.co\/wp-content\/uploads\/2021\/08\/shutterstock_1745457536-scaled-810x500-1.jpeg\")
Shutterstock<\/p><\/div>\n
Joel S. Hirschhorn<\/p>\n
(LifeSiteNews<\/a>) \u2013 Admittedly, people face a difficult decision on whether or not to take a COVID vaccine. So much information tells the ugly story of people who have suffered illness or death because they were not vaccinated. But Americans who have taken COVID vaccine shots and those who have refused to capitulate to the coercion and propaganda are ill-informed about blood clots, as well as about the limits of vaccines as shown by high numbers of breakthrough infections in the vaccinated.<\/p>\n If you only consider statistics about the number of people benefitting from vaccines versus lower numbers experiencing bad side effects, you might dismiss the negatives in favor of the positives.\u00a0But there is significant uncertainty about longer-term negative vaccine impacts that may affect a lot of vaccinated people.<\/p>\n This article provides summaries of key, recently published research on two types of observed blood clots \u2013 microscopic and relatively large size \u2013 that merit serious attention and concern.\u00a0One inevitable conclusion is that the FDA, with support from Big Media and the medical establishment, is not doing its job to ensure truly informed consent of those taking vaccine shots.<\/p>\n Dr. Charles Hoffe has been practicing medicine for 28 years in a small, rural town in British Columbia, Canada, and recently gave a long interview<\/a>.\u00a0He has given about 900 doses of the Moderna experimental mRNA vaccine to his patients.\u00a0So, contrary to some critics, he is no anti-vaccine doctor.<\/p>\n The core problem he has seen are microscopic clots in his patients\u2019 tiniest capillaries.\u00a0He said, \u201cBlood clots occurring at a capillary level. This has never before been seen.\u00a0This is not a rare disease.\u00a0This is an absolutely new phenomenon.\u201d<\/p>\n Most importantly, he has emphasized these micro-clots are too small to show up on CT scans, MRI, and other conventional tests, such as angiograms, and can only be detected using the D-dimer blood test, a standard test that indicates whether blood clots are being actively formed somewhere within a person\u2019s vascular system.<\/p>\n Using the latter, he found that 62 percent of his patients injected with an mRNA shot were positive for clotting, not a small fraction that can be easily dismissed.<\/p>\n He has explained that what is happening in bodies is that the spike proteins in the vaccine become \u201cpart of the cell wall of your vascular endothelium. This means that these cells which line your blood vessels, which are supposed to be smooth so that your blood flows smoothly, now have these little spikey bits sticking out.\u00a0 \u2026 when the platelet comes through the capillary, it suddenly hits all these COVID spikes, and it becomes absolutely inevitable that blood clots will form to block that vessel.\u201d<\/p>\n He made an important distinction: \u201cThe blood clots we hear about, which the media claim are very rare, are the big blood clots, which are the ones that cause strokes and show up on CT scans, MRI, etc. The clots I\u2019m talking about are microscopic and too small to find on any scan. They can thus only be detected using the D-dimer test.\u201d<\/p>\n \u201cThe most alarming part of this is that there are some parts of the body like the brain, spinal cord, heart and lungs which cannot re-generate. When those tissues are damaged by blood clots, they are permanently damaged.\u201d<\/p>\n This is his pessimistic, scientific view: \u201cblood vessels in their lungs are now blocked up. In turn, this causes the heart to need to work harder to try to keep up against a much greater resistance trying to get the blood through your lungs. This is called pulmonary artery hypertension \u2013 high blood pressure in the lungs because the blood simply cannot get through effectively.<\/p>\n \u201cPeople with this condition usually die of heart failure within a few short years.\u201d<\/p>\n All these strong medical views have been suppressed by Big Media, but they were covered well in another\u00a0alternative news site.<\/a><\/p>\n And Hoffe got some attention by submitting an\u00a0open letter<\/a> to the provincial Ministry of Health.<\/p>\n A key point in that was this: \u201cIt must be emphasised, that these people were not sick people, being treated for some devastating disease. These were previously healthy people, who were offered an experimental therapy, with unknown long-term side-effects, to protect them against an illness that has the same mortality rate as the flu. Sadly, their lives have now been ruined.\u201d<\/p>\n The concept of micro blood clots has also been invoked by others for the serious impacts of COVID itself.\u00a0The eminent Dr. Peter McCullough noted<\/a>, \u201cSo, this is a very different type of blood clotting that we would see with major blood clots in the arteries and veins, for instance, blood clots involved in stroke and heart attack, blood clots involved in major blood vessels in the legs.\u00a0This was a different type of clotting, and in fact, the Italians courageously did some autopsies and found micro blood clots in the lungs.\u201d<\/p>\n \u201cAnd so, we understood in the end, the reason why the lungs fail is not because the virus is there. It is because micro blood clots are there. \u2026 When people can\u2019t breathe, the problem is micro blood clotting in the lungs. \u2026 The spicule on the ball of the virus itself which damages blood vessels that causes blood clotting.\u201d He has also openly stated that none of the COVID vaccines are safe for most people at little risk from COVID.<\/p>\n If spike protein is the cause of micro blood clots in COVID, it is also reasonable to see the same phenomenon in vaccinated people impregnated with spike proteins, as Dr. Hoffe explained.<\/p>\n As to the Canadian situation, the Public Health Agency of Canada (PHAC) in July estimated the rate of vaccine-related blood clotting in Canadians who have received the AstraZeneca vaccine and said there have been 27 confirmed cases to date in Canada, with five deaths among those cases \u2013 a rather high death rate.<\/p>\n But this is consistent with six out of 28 blood clot cases reported<\/a> by Yale University for the Johnson & Johnson vaccine in the U.S. Also noted was that these were a particularly rare and dangerous blood clot in the brain, known as cerebral venous sinus thrombosis (CVST), because it appears in the brain\u2019s venous sinuses. Also noted was that there were abnormally low platelet levels in the patients\u2019 blood, an unusual situation also found for those impacted by the AstraZeneca vaccine. Platelets are used to create blood clots.<\/p>\n There is a very important\u00a0video<\/a>\u00a0of an August presentation by the highly credentialed and experienced pathologist Dr. Ryan Cole on the topic \u201cWhat the vaccine spike protein does to the body.\u201d\u00a0This video shows a large number of medical slides of different kinds of tissues in COVID vaccine victims obtained typically from autopsies.\u00a0Dr. Cole shows many examples of microscopic blood clots in key tissues, such as from lungs. His detailed work strongly supports what Dr. Hoffe has found and discussed.<\/p>\n In June, former Pfizer executive Dr. Michael Yeadon\u00a0added his voice<\/a> of deep expertise on vaccines to the blood clot issue. \u201cThese COVID vaccines are not safe,\u201d he said. \u201cThe gene-based design makes your body manufacture virus spike protein, and we know, and we\u2019ve known for years, that virus spike protein triggers blood clots,\u201d Yeadon explained. \u201cThat\u2019s a fundamental problem.\u201d<\/p>\n Dr. Yeadon revealed the astronomically high adverse events from the vaccine alone should have shut them down.\u00a0\u201cYoung people are not susceptible to COVID-19.\u00a0They\u2019re not at risk,\u201d Dr. Yeadon said. \u201cIt\u2019s a crazy thing then to vaccinate them with something that is actually 50 times more likely to kill them than the virus itself.\u201d<\/p>\n Dr. Yeadon said that the CDC\u2019s VAERS vaccine injury tracking system has reported roughly 5,000 vaccine deaths in the first six months of 2021.\u00a0\u201cNormally there\u2019s 200 a year for all vaccines combined,\u201d he said.<\/p>\n \u201cI\u2019m very pro-vaccines,\u201d Yeadon said. \u201cMy biggest beef with the [COVID] vaccines include serious concerns about safety.\u00a0They have not been sufficiently tested,\u201d he explained. \u201cThey were approved for emergency use fraudulently, in my view, because they shouldn\u2019t do it if there are safe and effective medicines.\u00a0And there are.\u00a0They have just been hidden.\u201d<\/p>\n Yeadon said hydroxychloroquine, ivermectin, azithromycin, and inhaled steroids are all safe and effective at treating the coronavirus. Each was suppressed by Dr. Anthony Fauci, the scientific establishment, and the media. That is exactly the truth.<\/p>\n A July medical research\u00a0article<\/a>\u00a0by two distinguished physicians, Michael Palmer and Sucharit Bhakdi, associated with the group Doctors for COVID Ethics, examined the original research done for the Pfizer mRNA vaccine.\u00a0Here are highlights from this important paper:<\/p>\n \u201cThe dangers of the COVID-19 vaccine spike protein and its interactions with the human immune system, conferring risks of clotting and leakage of blood vessels, are becoming increasingly well known.\u00a0But how far and wide in the body can such dangers spread?\u00a0What does that mean for vaccine safety?\u201d<\/p>\n \u201cWe summarize the findings of an animal study which Pfizer submitted to the Japanese health authorities in 2020, and which pertained to the distribution and elimination of a model mRNA vaccine.\u00a0We show that this study clearly presaged grave risks of blood clotting and other adverse effects.\u00a0The failure to monitor and assess these risks in the subsequent clinical trials, and the grossly negligent review process in conjunction with the emergency use authorizations, have predictably resulted in an unprecedented medical disaster.\u201d<\/p>\n \u201cPfizer\u2019s animal data clearly presaged the following risks and dangers: blood clotting shortly after vaccination, potentially leading to heart attacks, stroke, and venous thrombosis.\u201d<\/p>\n \u201cWe must emphasize again that each of these risks could readily be inferred from the cited limited preclinical data, but were not followed up with appropriate in-depth investigations.\u00a0In particular, the clinical trials did not monitor any laboratory parameters that could have provided information on these risks, such as those related to blood coagulation (e.g. D-dimers\/thrombocytes), muscle cell damage (e.g. troponin\/creatine kinase), or liver damage (e.g. \u03b3-glutamyltransferase). That the various regulatory agencies granted emergency use authorization based on such incomplete and insufficient data amounts to nothing less than gross negligence.\u201d<\/p>\n \u201cSince the so-called clinical trials were carried out with such negligence, the real trials are occurring only now\u2014on a massive scale, and with devastating results.\u00a0This vaccine, and others, are often called \u2018experimental.\u2019\u00a0Calling off this failed experiment is long overdue. Continuing or even mandating the use of this poisonous vaccine, and the apparently imminent issuance of full approval for it are crimes against humanity.\u201d<\/p>\n The strong language used by these doctors is worth serious consideration.<\/p>\n In June, a\u00a0medical paper<\/a>\u00a0by experienced European physicians and medical researchers described four cases of patients who suffered from COVID vaccine-induced blood clots.\u00a0They presented with varying symptoms that posed challenges for doctors to address.\u00a0Here are some highlights from this paper:<\/p>\n \u201cVaccine-induced immune thrombotic thrombocytopenia (VITT) is a novel entity that emerged in March 2021 following reports of unusual thrombosis after (AstraZeneca) vaccination. \u2026 The present study highlights the issues associated with the recognition of VITT, the limitations of current guidance and the need for heightened clinical vigilance as our understanding of the pathophysiology of this novel condition evolves.\u00a0\u2026 As of 4 April 2021, a total of 169 cases of cerebral venous sinus thrombosis (CVST) and 53 cases of splanchnic vein thrombosis (SVT) had been reported to the European drug safety database EudraVigilance.\u201d<\/p>\n \u201cOver recent weeks, the concept of VITT has emerged as an entirely novel clinical entity that can be associated with significant morbidity and mortality, even in young and otherwise healthy recipients.\u00a0The limited clinical data regarding this rare disorder associated with use of coronavirus disease 2019 (COVID-19) adenoviral vaccines has posed significant clinical challenges.\u201d<\/p>\n \u201cWe believe that the clinico-pathological spectrum associated with VITT may be much wider than first envisaged.\u00a0This hypothesis is supported by the cases presented in the present study.\u201d<\/p>\n \u201cWith improved awareness of this condition it is more likely that patients may present earlier, while the disorder is still in evolution.\u201d<\/p>\n What is clear is that the blood clot condition in vaccinated people is serious, and the medical community\u2019s ability to address the problem is far from proven.<\/p>\n To its credit, the Wall Street Journal<\/em> published a\u00a0long article<\/a>\u00a0in July on the COVID vaccine blood clot issue.\u00a0Here are highlights from it:<\/p>\n \u201cCanadian researchers say they have pinpointed a handful of amino acids targeted by key antibodies in the blood of some people who received the AstraZeneca Covid-19 vaccine, offering fresh clues to what causes rare blood clots associated with the shot.\u201d<\/p>\n \u201cThe peer-reviewed findings, by a team of researchers from McMaster University in Ontario, were published \u2026 by the science journal Nature<\/a>. They could help doctors rapidly test for and treat the unusual clotting, arising from an immune-driven mix of coagulation and loss of platelets that stop bleeding.\u201d<\/p>\n \u201cThe blood clotting, which some scientists have named vaccine-induced immune thrombotic thrombocytopenia, or VITT, has also been linked to Johnson & Johnson\u2019s Covid-19 shot, though incidents have occurred less frequently with that shot than with AstraZeneca.\u201d\u00a0Think of VITT as a medical term for blood clotting.<\/p>\n \u201cThough rare, the condition has proven deadly in more than 170 adults post-vaccination in the U.K., Europe and U.S., according to government tallies.\u00a0Many were younger adults who appeared healthy before vaccination, researchers and drug regulators say.\u201d<\/p>\n \u201cThe total number of cases after first or second doses in the U.K. was 395 through June 23 \u2026 Of the 395, 70 people have died. European officials said this month that they have seen 479 potential cases of VITT out of 51.4 million AstraZeneca vaccinations \u2026 Far fewer potential cases \u2014 21 \u2026 followed J&J vaccinations in Europe. Of those cases, 100 deaths occurred after AstraZeneca vaccination and four after Johnson & Johnson, European regulators said.\u201d<\/p>\n \u201cU.S. health officials said in late June that they have identified 38 confirmed cases of the blood-clotting syndrome out of more than 12.3 million people who received the J&J vaccine \u2026 The Centers for Disease Control and Prevention said in May that three cases had been fatal and evidence \u2018suggests a plausible causal association between the combination of low platelets and clotting and the vaccine.\u2019\u201d Again, that combination is a very serious medical condition that can explain serious bleeding events.<\/p>\n As to what is going on inside the body: \u201c[In] rare cases, vaccinated people have experienced an autoimmune reaction in which antibodies bind with unusual strength to a blood component called platelet factor 4, or PF4, forming distinct clusters resembling a bunch of grapes.\u201d<\/p>\n \u201cThis so-called immune complex, a molecular formation in the blood, activates more platelets, \u2018like putting a match to gasoline,\u2019 said John Kelton, an author of the Nature paper and researcher at McMaster University. The process accelerates, he and other researchers say, triggering simultaneous bleeding and clotting, sometimes in the brain, stomach and other areas that can in rare cases be deadly. \u2018We think these antibodies are incredible amplifiers, in a bad way, of the normal coagulation system,\u2019 said Dr. Kelton\u201d<\/p>\n Interestingly, this article did not mention the previously discussed case of the Canadian doctor and his findings about microscopic blood clotting.<\/p>\n In April, there was limited\u00a0coverage<\/a>\u00a0of stoppages of some vaccines: \u201cFirst it was AstraZeneca. Now Johnson & Johnson.\u00a0Last week, British regulators and the European Union\u2019s medical agency said they had established a possible link between AstraZeneca\u2019s Covid-19 vaccine and very rare, though sometimes fatal, blood clot,\u201d the New York Times<\/em> stated.<\/p>\n \u201cThe pause in the use of Johnson & Johnson\u2019s vaccine in Europe over similar concerns threatens to hurt a sluggish rollout that was just starting to gain momentum.\u201d\u00a0Also noted was that states paused use of the J&J vaccine after a U.S. advisory.<\/p>\n \u201cRegulators have asked vaccine recipients and doctors to look out for certain symptoms, including severe and persistent headaches and tiny blood spots under the skin.\u201d<\/p>\n In April, this journal published three research articles on blood clotting related to COVID vaccines and a long\u00a0editorial<\/a> by two physicians reviewing all the work. Here are highlights from the latter:<\/p>\n \u201cThe Journal has now highlighted three independent descriptions of 39 persons with a newly described syndrome characterized by thrombosis and thrombocytopenia that developed 5 to 24 days after initial vaccination with [the AstraZeneca vaccine]. \u2026 These persons were healthy or in medically stable condition, and very few were known to have had previous thrombosis or a preexisting prothrombotic condition. Most of the patients included in these reports were women younger than 50 years of age, some of whom were receiving estrogen-replacement therapy or oral contraceptives.\u201d<\/p>\n \u201cA remarkably high percentage of the patients had thromboses at unusual sites \u2014 specifically, cerebral venous sinus thrombosis or thrombosis in the portal, splanchnic, or hepatic veins.\u00a0Other patients presented with deep venous thrombi, pulmonary emboli, or acute arterial thromboses. \u2026 High levels of d-dimers and low levels of fibrinogen were common and suggest systemic activation of coagulation.\u00a0Approximately 40% of the patients died, some from ischemic brain injury, superimposed hemorrhage, or both conditions, often after anticoagulation.\u201d<\/p>\n \u201cBetter understanding of how the vaccine induces these platelet-activating antibodies might also provide insight into the duration of antigen exposure and the risk of reoccurrence of thrombosis, which will inform the need for extended anticoagulation and might lead to improvements in vaccine design.\u201d<\/p>\n \u201cAdditional cases have now been reported to the European Medicines Agency, including at least 169 possible cases of cerebral venous sinus thrombosis and 53 possible cases of splanchnic vein thrombosis among 34 million recipients of the [AstraZeneca] vaccine, 35 possible cases of central nervous system thrombosis among 54 million recipients of the Pfizer\u2013BioNTech mRNA vaccine, and 5 possible (but unvetted) cases of cerebral venous sinus thrombosis among 4 million recipients of the Moderna mRNA vaccine.\u201d<\/p>\n \u201cSix possible cases of cerebral venous sinus thrombosis (with or without splanchnic vein thrombosis) have been reported among the more than 7 million recipients of the Johnson & Johnson\/Janssen vaccine.\u201d<\/p>\n Here is the final conclusion: \u201cThe questions of whether certain populations can be identified as more suitable candidates for one or another vaccine and who and how to monitor for this rare potential complication will require additional study.\u201d But it is not clear whether the CDC and NIH are funding such work.<\/p>\n In April, the Salk Institute\u00a0promoted coverage<\/a>\u00a0of research conducted by a number of people associated with it.\u00a0The chief finding was that the spike protein associated with the COVID virus and with vaccines was connected to strokes, heart attacks, and blood clots.<\/p>\n \u201cThe paper, published in\u00a0Circulation Research<\/a>, also shows conclusively that COVID-19 is a vascular disease, demonstrating exactly how the SARS-CoV-2 virus damages and attacks the vascular system on a cellular level.\u00a0 \u2026 the paper provides clear confirmation and a detailed explanation of the mechanism through which the [spike] protein damages vascular cells.\u201d<\/p>\n A\u00a0subsequent article<\/a> in May examined this work and made several important observations. Here is its perspective, as it relates to the COVID vaccines:<\/p>\n \u201cThe prestigious Salk Institute \u2026 has authored and published the bombshell scientific study revealing that the SARS-CoV-2 spike protein used in the Covid jabs is what\u2019s actually causing vascular damage.\u00a0Critically, all three of the experimental Covid vaccines currently under emergency use authorisation in the UK either inject patients with the spike protein or, via mRNA technology, instruct the patient\u2019s own body to manufacture the spike protein and release them into the blood system.\u201d<\/p>\n \u201cThe Salk Institute study proves the assumption made by the vaccine industry, that the spike protein is inert and harmless, to be false and dangerously inaccurate.\u201d<\/p>\n \u201cThe research proves that the Covid vaccines are capable of inducing vascular disease and directly causing injuries and deaths stemming to blood clots and other vascular reactions.\u00a0This is all caused by the spike protein that\u2019s engineered into the vaccines.\u201d<\/p>\n This May\u00a0report<\/a> was prepared by nearly five dozen highly respected doctors, scientists, and public policy experts from across the globe. It went public and was urgently sent to world leaders, as well as to all who are associated with the production and distribution of the various COVID-19 vaccines in circulation today. The report demanded an immediate stop to COVID vaccinations. Dr. McCullough was one of the signatories.<\/p>\n \u201cDespite calls for caution, the risks of SARS-CoV-2 vaccination have been minimized or ignored by health organizations and government authorities,\u201d said the experts.<\/p>\n On the issue of blood clotting in vaccinated people the report said this:<\/p>\n \u201cSome adverse reactions, including blood-clotting disorders, have already been reported in healthy and young vaccinated people. These cases led to the suspension or cancellation of the use of adenoviral vectorized [AstraZeneca] and [J&J] vaccines in some countries. It has now been proposed that vaccination with [the AstraZeneca vaccine] can result in immune thrombotic thrombocytopenia (VITT) mediated by platelet-activating antibodies against Platelet factor-4, which clinically mimics autoimmune heparin-induced thrombocytopenia.\u201d<\/p>\n \u201cUnfortunately, the risk was overlooked when authorizing these vaccines, although adenovirus-induced thrombocytopenia has been known for more than a decade, and has been a consistent event with adenoviral vectors.\u00a0The risk of VITT would presumably be higher in those already at risk of blood clots, including women who use oral contraceptives, making it imperative for clinicians to advise their patients accordingly.\u201d<\/p>\n Here is the vaccine quandary: Supporters of the COVID vaccines are quick to emphasize that relatively few recipients have experienced post-vaccination blood clotting.\u00a0True, except for the findings of the Canadian physician about microscopic blood clots in most of his patients that major news media have ignored.\u00a0Also ignored are the findings from the Salk Institute which provide a rationale for seeing spike proteins as causing clots.<\/p>\n Even vaccines not directly including spike proteins \u2013 the AstraZeneca and J&J adenovirus vector vaccines \u2013 pose a problem because they send genetic instructions into cells to produce the spike protein of the coronavirus.<\/p>\n Even a June\u00a0case study<\/a> of one patient who died from clotting after taking the second dose of the Moderna vaccine, unrelated to anything else, stressed the use of \u201csafe\u201d COVID vaccines. This was also stressed in an accompanying editorial<\/a> that mentioned, \u201cThe highest reported incidence is 5 cases among about 130,000 Norwegian recipients of the [AstraZeneca] vaccine.\u201d<\/p>\n This statistical view of the medical establishment was expressed as: \u201cany potential risks of vaccination must be interpreted in the context of the overall morbidity and mortality of COVID-19 itself.\u201d\u00a0It also stressed blood clots in hospitalized COVID patients.<\/p>\n It cannot be emphasized enough that the vast majority of COVID victims \u2013 over 500,000 of the over 600,000 official COVID deaths in the U.S. \u2013 could have been saved through early home\/outpatient treatment as detailed in\u00a0Pandemic Blunder<\/a>.\u00a0The proven treatments can stop COVID infection in its early virus replication phase and, therefore, prevent blood clots as the infection progresses.<\/p>\n The public also needs strong information about the many advantages of natural immunity, from prior COVID infection or life exposure to various coronaviruses. This is far better than vaccine-induced artificial immunity that does less to protect against COVID variants and makes people susceptible to breakthrough infections.<\/p>\n For most healthy, relatively young (less than age 70) people, the benefits of COVID vaccination do not outweigh the risks. Dr. McCullough was correct in saying that the better approach to COVID vaccination would have limited it to perhaps 20 million Americans with serious COVID risks.<\/p>\n On the issue of whether all COVID vaccines pose a blood clot threat, consider an April\u00a0study by Oxford University<\/a>\u00a0that found the number of people who receive blood clots after getting vaccinated with a coronavirus vaccine are about the same for those who get Pfizer and Moderna vaccines as they are for the AstraZeneca vaccine.\u00a0And as already cited, the J&J vaccine has also been implicated for clots.<\/p>\n What needs attention by the FDA, CDC, and NIH is the need to do more testing of vaccine victims to discover through blood testing or autopsies the nature and extent of blood clotting. Thus the importance of the work of pathology expert Dr. Cole.<\/p>\n For those wanting to see many examples of COVID vaccine negative health impacts, this\u00a0website<\/a>\u00a0is recommended.\u00a0The mission is: \u201cThis website is dedicated to sharing the truth about these people and their testimonials.\u00a0Watch for yourself and make up your own mind.\u00a0Is it worth it to risk life-changing and even fatal side effects from a vaccine for a disease that is survived by 99.98% of people under 70?\u201d<\/p>\n Of course, the risk of getting serious blood clots seems much higher for those who get a serious case COVID-19 then it is for those who get vaccinated.\u00a0They tend to be acute, near-term impacts amenable to various treatments, though, sadly, not life-saving in all cases.<\/p>\n More insidious, in the longer run, however, perhaps years after the shots, are the microscopic blood clots noted by Dr. Hoffe and Dr. McCullough, and revealed through tissue examination by Dr. Cole, that may impact the lives of many people \u2013 perhaps millions.<\/p>\nCanadian physician reports high levels of clots<\/h4>\n
Dr. Ryan Cole \u2013 proof of blood clots from a pathology expert<\/h4>\n
Expertise of former Pfizer executive<\/h4>\n
Research from Doctors for COVID Ethics<\/h4>\n
Research from Europe on victims of vaccine-induced blood clots<\/h4>\n
Wall Street Journal and Nature<\/h4>\n
New York Times<\/h4>\n
New England Journal of Medicine<\/h4>\n
Salk Institute<\/h4>\n
Report by 57 Medical Experts<\/h4>\n
Conclusions<\/h4>\n